My Companies
Notification
Account
Log Out
Login
FY27 guide revised to single-digit revenue degrowth, mid-20s EBITDA margin. Q1 rev -16% YoY. MoU with THSTI for clinical development.
Syngene CFO Deepak Jain Exits Amid Wider Executive Leadership Reshuffle
Syngene International Appoints Siddharth Mittal as Managing Director & CEO